Patterson Sue, Weaver Tim, Agath Kostas, Albert Eliot, Rhodes Timothy, Rutter Deborah, Crawford Mike
Department of Psychological Medicine, Faculty of Medicine, Imperial College, London, England.
Health Soc Care Community. 2009 Feb;17(1):54-62. doi: 10.1111/j.1365-2524.2008.00797.x. Epub 2008 Jun 17.
Providers of public health care are under pressure to involve service-users in service development. This pressure emanates from legislators and the public who promote user involvement (UI), as a 'means to an end' and/or 'an end in itself'. Case studies in six English commissioning areas explored the process and purpose of UI in drug treatment services. In-depth interviews with 139 respondents who commission, manage, deliver or use services were conducted. We identified 'non-', 'passive-' and 'active participant' users. Active users were commonly motivated by a desire for social justice, a social conscience and personal development. UI was evidently influenced by multiple social organizational and personal factors. Some 'generic' factors have been reported in other settings. However, the illegality of drug use powerfully affects all stakeholders creating a context unique to drug treatment settings. Stigma and power imbalances were pervasive, and strong tensions concerning the goal and purpose of UI were apparent. Within the UK context, we identified five organizational approaches to UI. Based on rationale and objectives of UI, and the scope of influence accorded users, organizations could be characterised as protagonists, pragmatists, sceptics, abstainers or avoiders. We conclude that many tensions apparent in local level UI have roots in UI policy, which is ambiguous about: (1) benefit and rights, and (2) the promotion of healthcare objectives within a UK drug strategy driven by a crime reduction agenda. This duality must be resolved for UI to flourish at local level.
公共卫生保健服务提供者面临着让服务使用者参与服务开发的压力。这种压力来自于倡导使用者参与(UI)的立法者和公众,他们将其视为“达到目的的手段”和/或“目的本身”。对英国六个委托区域的案例研究探讨了药物治疗服务中使用者参与的过程和目的。对139名参与委托、管理、提供或使用服务的受访者进行了深入访谈。我们识别出了“非参与者”“被动参与者”和“主动参与者”三类使用者。主动使用者通常受到对社会正义、社会良知和个人发展渴望的驱使。使用者参与显然受到多种社会、组织和个人因素的影响。在其他环境中也报道过一些“一般性”因素。然而,药物使用的非法性对所有利益相关者都产生了强大影响,营造了药物治疗环境特有的背景。耻辱感和权力失衡普遍存在,关于使用者参与的目标和目的存在明显的强烈矛盾。在英国的背景下,我们识别出了五种组织层面的使用者参与方式。根据使用者参与的基本原理和目标以及赋予使用者的影响范围,组织可被归类为主角型、实用主义型、怀疑型、弃权型或回避型。我们得出结论,地方层面使用者参与中许多明显的矛盾根源在于使用者参与政策,该政策在以下两方面含糊不清:(1)益处和权利;(2)在由减少犯罪议程驱动的英国毒品战略中促进医疗保健目标。为了让使用者参与在地方层面蓬勃发展,这种二元性必须得到解决。